BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22814582)

  • 1. Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.
    Zhang YQ; Pilyugin M; Kuester D; Leoni VP; Li L; Casula G; Zorcolo L; Schneider-Stock R; Atzori L; Irminger-Finger I
    Br J Cancer; 2012 Aug; 107(4):675-83. PubMed ID: 22814582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BARD1: an independent predictor of survival in non-small cell lung cancer.
    Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
    Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BARD1 expression predicts outcome in colon cancer.
    Sporn JC; Hothorn T; Jung B
    Clin Cancer Res; 2011 Aug; 17(16):5451-62. PubMed ID: 21693656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
    Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues.
    Lombardi G; Falaschi E; Di Cristofano C; Naccarato AG; Sensi E; Aretini P; Roncella M; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2007 Sep; 46(9):791-5. PubMed ID: 17497650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
    Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
    Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
    Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
    Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.
    Ryser S; Dizin E; Jefford CE; Delaval B; Gagos S; Christodoulidou A; Krause KH; Birnbaum D; Irminger-Finger I
    Cancer Res; 2009 Feb; 69(3):1125-34. PubMed ID: 19176389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BARD1 mediates TGF-β signaling in pulmonary fibrosis.
    André PA; Prêle CM; Vierkotten S; Carnesecchi S; Donati Y; Chambers RC; Pache JC; Crestani B; Barazzone-Argiroffo C; Königshoff M; Laurent GJ; Irminger-Finger I
    Respir Res; 2015 Sep; 16():118. PubMed ID: 26415510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
    Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.
    Brodie KM; Mok MTS; Henderson BR
    Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.
    Pilyugin M; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Sep; 54():356-67. PubMed ID: 25008968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts on BARD1: Regulator of BRCA pathways and beyond.
    Irminger-Finger I; Ratajska M; Pilyugin M
    Int J Biochem Cell Biol; 2016 Mar; 72():1-17. PubMed ID: 26738429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women.
    Śniadecki M; Brzeziński M; Darecka K; Klasa-Mazurkiewicz D; Poniewierza P; Krzeszowiec M; Kmieć N; Wydra D
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
    Liao Y; Yuan S; Chen X; Zhu P; Li J; Qin L; Liao W
    Sci Rep; 2017 Aug; 7(1):7649. PubMed ID: 28794477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability.
    Pilyugin M; André PA; Ratajska M; Kuzniacka A; Limon J; Tournier BB; Colas J; Laurent G; Irminger-Finger I
    Oncotarget; 2017 Feb; 8(6):9339-9353. PubMed ID: 28030839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
    Ratajska M; Matusiak M; Kuzniacka A; Wasag B; Brozek I; Biernat W; Koczkowska M; Debniak J; Sniadecki M; Kozlowski P; Klonowska K; Pilyugin M; Wydra D; Laurent G; Limon J; Irminger-Finger I
    Oncol Rep; 2015 Nov; 34(5):2609-17. PubMed ID: 26329992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BARD1 mystery: tumor suppressors are cancer susceptibility genes.
    Hawsawi YM; Shams A; Theyab A; Abdali WA; Hussien NA; Alatwi HE; Alzahrani OR; Oyouni AAA; Babalghith AO; Alreshidi M
    BMC Cancer; 2022 Jun; 22(1):599. PubMed ID: 35650591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA Processing Factor CstF-50 and Ubiquitin Escort Factor p97 Are BRCA1/BARD1 Cofactors Involved in Chromatin Remodeling during the DNA Damage Response.
    Fonseca D; Baquero J; Murphy MR; Aruggoda G; Varriano S; Sapienza C; Mashadova O; Rahman S; Kleiman FE
    Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29180510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.